Showing results (201-210 of 238) with videos related to
Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patientsJoanne M de Laat, Carolina R Pieterman, Medard F van den Broek, et al.European Journal of Endocrinology|February 18, 2016
Potential value of EUS in pancreatic surveillance of VHL patientsSophie J van Asselt, Adrienne H Brouwers, Hendrik M van Dullemen, et al.European Journal of Endocrinology|April 16, 2013
Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinomaIlse G C Hermsen, Harm R Haak, Ronald R de Krijger, et al.Orphanet Journal of Rare Diseases|September 17, 2013
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylaseJohannes Hofland, Leo J Hofland, Peter M van Koetsveld, et al.Lancet (London, England)|June 8, 2024
[<sup>177</sup>Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studySimron Singh, Daniel Halperin, Sten Myrehaug, et al.The Journal of Clinical Endocrinology and Metabolism|January 12, 2016
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Bernadette P M van Nesselrooij, Ad R Hermus, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Koen M Dreijerink, Margreet G Ausems, et al.BMC Medicine|November 16, 2016
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsJoanne M de Laat, Rob B van der Luijt, Carolina R C Pieterman, et al.Journal of Surgical Oncology|August 12, 2019
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)Dirk-Jan van Beek, Sjoerd Nell, Carolina R C Pieterman, et al.BMC Gastroenterology|June 16, 2018
Additional hepatic <sup>166</sup>Ho-radioembolization in patients with neuroendocrine tumours treated with <sup>177</sup>Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)Arthur J A T Braat, Dik J Kwekkeboom, Boen L R Kam, et al.Pageof 24